Position
Parallel Advisors, LLC in Sarepta Therapeutics, Inc.
Back to the book · All holders of SRPT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $504$21.52 → $21.76
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.1K | $45.2K | — | — | — | 0.0% |
| Q1 2026 | 2.54K | $55.2K | $21.76 | $504 | $9.47K | 0.0% |